Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Contacts and Locations
Related Studies
Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI
This study is ongoing, but not recruiting participants.
Information provided by Universitaria di Ferrara
Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1
Conditions listed in this trial
Myocardial Infarction
2
Additional conditions recognized in this trial
Infarction
3
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Ischemia
Myocardial Ischemia
Necrosis
Pathologic Processes
Vascular Diseases
4
Interventions listed in this trial
tirofiban and bare metal stent
5
Additional drug interventions recognized in this trial
Abciximab
PS-K
Sirolimus
Tirofiban
6
More general drug interventions related to this trial
Adjuvants, Immunologic
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Anticoagulants
Antifungal Agents
Antineoplastic Agents
Antiviral Agents
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Immunologic Factors
Immunosuppressive Agents
Interferon Inducers
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Protective Agents
Radiation-Protective Agents
Therapeutic Uses
7
Sponsors listed in this trial
Universitaria di Ferrara
U.S. National Library of Medicine
,
Contact Help Desk
U.S. National Institutes of Health
,
U.S. Department of Health & Human Services
,
USA.gov
,
Copyright
,
Privacy
,
Accessibility
,
Freedom of Information Act
Links to all studies - primarily for crawlers